Hello! Describe your research question and I'll help you find matching datasets across 2,944 studies from AnVIL, BDC, CRDC, and KFDRC.

The CHK1 Inhibitor Prexasertib in BRCA Wild-Type Platinum-Resistant Recurrent High-Grade Serous Ovarian Carcinoma: a Phase 2 Trial

Description
Platforms
dbGaP
View in dbGaP
Summary
Consent CodesUnspecified
Focus / DiseasesOvarian Neoplasms
Study DesignClinical Trial
Data TypesWXS
Subjects18